Navigation Links
Seneca Valley High School Student Receives Science Award From MedImmune
Date:3/27/2008

GAITHERSBURG, Md., March 27 /PRNewswire/ -- Local biotechnology leader MedImmune announced today that Seneca Valley High School student Yiwei Li has received the distinguished "MedImmune Advancing Science for Better Health" award for her ScienceMONTGOMERY project. The company sponsored the Montgomery County science fair, known as ScienceMONTGOMERY, for the fourth-consecutive year and presented the award to recognize the scientific work of a current Montgomery County high school junior or senior. On March 16 at Gaithersburg High School, MedImmune awarded Li for her project entitled "Discovering New Splicing Forms in von Willebrand Factor to Understand Clotting Diseases."

Li's project was judged as the best example of an individual project with biological relevance to the causes, treatment and prevention of human disease in the medicine and health category. The team of MedImmune judges reviewed individual projects in the fields of biochemistry, environmental sciences (life), medicine and health, microbiology and biological sciences. Criteria for evaluation included alignment with MedImmune's core values: an entrepreneurial spirit, high integrity, collaboration and a strong work ethic.

"Li's work stood out from the very impressive collection of projects that were submitted this year," said employee judge Toni Stiefel, director, internal communications and community relations at MedImmune, "We believed her presentation was well thought out, and her commitment to post-submission research was commendable. These attributes and a sense of drive set Li apart."

As part of the project submitted, Li was interested in von Willebrand disease (VWD) and understanding the application of alternative splicing in individuals. VWD is an inherited bleeding disorder that affects the blood's ability to clot. Von Willebrand factor (VWF) is a protein that helps bind platelets together to form blood clots, and was expected to have around 22 to 23 alternative splicing forms. With one splicing form already known, Li set out to discover some, if not most, of the remaining forms. "By examining splicing forms in VWF, I hoped to find and conduct research on those varying mRNA sequences in order to help patients with VWD and to further promote an understanding of the disease," said Li.

Li is continuing to conduct more experiments as part of her project and hopes to conclude, before her graduation in June 2008, whether or not adipose tissue exhibits an alternative splicing form. In the future, she intends to pursue a career in the medical field working with VWD patients and advancing this field of research. For her outstanding efforts, Li received a trophy, an award certificate, a gift card and an offer for a six-week paid internship at MedImmune.

"One of our primary objectives at MedImmune is to promote and advance health and science education," Stiefel said. "Our support of the Montgomery County Science Fair gives us an opportunity to invest in our local community and foster long-term development of students as they pursue careers in science." The Montgomery County Fair sponsorship is an example of MedImmune's commitment to support science and health education. The organization will sponsor four different science fairs across the country in areas where MedImmune has a large presence.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on cardiovascular/gastrointestinal disease, neuroscience, oncology, infection, respiratory disease and inflammation. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.


'/>"/>
SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
2. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
3. Ventria Receives Friends of Education Award From Geary County School District
4. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
5. First European IGRT School Takes Place for Radiotherapy Practitioners in UK
6. UCB Crohns Scholarship Program to Award $300,000 to Students with Crohns Disease
7. MichBio Announces Student Career Day at Michigan State University
8. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
9. CCMR gets $2.9M for training grad students in nanoscale science
10. CCMR gets $2.9M for training grad students in nanoscale science
11. Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 28, 2017 Summary This report ... Biochem and its partnering interests and activities since 2010. ... an in-depth insight into the partnering activity of one of ... company reports are prepared upon purchase to ensure inclusion of ... The report will be delivered in PDF format within ...
(Date:3/28/2017)... March 28, 2017  The National Pharmaceutical Council (NPC) ... health policy research organization as its newest member. ... Affairs ( North America ), will serve ... "We,re pleased to have Ipsen and Dr. ... Dan Leonard . "We welcome their insights in helping ...
(Date:3/28/2017)... -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or ... to treat cancers and other life-threatening conditions of the ... McGorry, CEO of Biostage, will present on the ... MassBio 2017 Annual Meeting on Thursday, March ... The 3D Printing and BioEngineering panel will ...
(Date:3/28/2017)... Focus is on the ... to the scientifically intensive operations of companies in ... and industrial. In today,s pre-market research, Stock-Callers.com dedicates attention ... PTLA), OvaScience Inc. (NASDAQ: OVAS), Ocera Therapeutics Inc. ... OCUL ). Learn more about these stocks ...
Breaking Biology Technology:
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
Breaking Biology News(10 mins):